172 related articles for article (PubMed ID: 28189846)
1. Isolevuglandins as a gauge of lipid peroxidation in human tumors.
Yan HP; Roberts LJ; Davies SS; Pohlmann P; Parl FF; Estes S; Maeng J; Parker B; Mernaugh R
Free Radic Biol Med; 2017 May; 106():62-68. PubMed ID: 28189846
[TBL] [Abstract][Full Text] [Related]
2. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.
Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K
Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721
[TBL] [Abstract][Full Text] [Related]
3. Isolevuglandin adducts in disease.
Salomon RG; Bi W
Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
[TBL] [Abstract][Full Text] [Related]
4. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
[TBL] [Abstract][Full Text] [Related]
5. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
[TBL] [Abstract][Full Text] [Related]
6. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
Salomon RG
Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
[TBL] [Abstract][Full Text] [Related]
7. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.
Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL
FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983
[TBL] [Abstract][Full Text] [Related]
8. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
9. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
10. Oxidized phospholipids, isolevuglandins, and atherosclerosis.
Zhang W; Salomon RG
Mol Nutr Food Res; 2005 Nov; 49(11):1050-62. PubMed ID: 16270278
[TBL] [Abstract][Full Text] [Related]
11. Direct Detection of Isolevuglandins in Tissues using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence.
Warden C; Simmons AJ; Pasic L; Pitzer A; Davies SS; Layer JH; Mernaugh RL; Kirabo A
J Vis Exp; 2021 Jul; (173):. PubMed ID: 34279509
[TBL] [Abstract][Full Text] [Related]
12. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT
Cells; 2024 Mar; 13(6):. PubMed ID: 38534327
[TBL] [Abstract][Full Text] [Related]
13. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria.
Zhong H; Yin H
Redox Biol; 2015; 4():193-9. PubMed ID: 25598486
[TBL] [Abstract][Full Text] [Related]
14. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis.
Salomon RG
Ann N Y Acad Sci; 2005 Jun; 1043():327-42. PubMed ID: 16037255
[TBL] [Abstract][Full Text] [Related]
15. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG
Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006
[TBL] [Abstract][Full Text] [Related]
16. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
Salomon RG; Batyreva E; Kaur K; Sprecher DL; Schreiber MJ; Crabb JW; Penn MS; DiCorletoe AM; Hazen SL; Podrez EA
Biochim Biophys Acta; 2000 May; 1485(2-3):225-35. PubMed ID: 10832102
[TBL] [Abstract][Full Text] [Related]
17. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
[TBL] [Abstract][Full Text] [Related]
18. Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells.
Maulucci G; Daniel B; Cohen O; Avrahami Y; Sasson S
Mol Aspects Med; 2016 Jun; 49():49-77. PubMed ID: 27012748
[TBL] [Abstract][Full Text] [Related]
19. [Processes of free radical lipid peroxidation with a particular regard to the role of paraoxonase-1 in the pathogenesis of multiple sclerosis].
Berbecki J; Mitosek-Szewczyk K; Kurzepa J; Nastaj M; Łobejko K; Stelmasiak Z
Wiad Lek; 2011; 64(1):31-6. PubMed ID: 21812361
[TBL] [Abstract][Full Text] [Related]
20. Reactive aldehydes--second messengers of free radicals in diabetes mellitus.
Jaganjac M; Tirosh O; Cohen G; Sasson S; Zarkovic N
Free Radic Res; 2013 Aug; 47 Suppl 1():39-48. PubMed ID: 23521622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
